International Journal of Chronic Diseases

Editorial Board

Academic Editors

  • Sulaiman M. Al-Mayouf, Alfaisal University, Saudi Arabia
  • Cristiano Feijó Andrade , Hospital de Clinicas de Porto Alegre, Brazil
  • Jack Arbiser, Emory University, USA
  • Mehmet Artac , Necmettin Erbakan University, Turkey
  • Mariano Bizzarri , Sapienza Università di Roma, Italy
  • Vincenzo Canzonieri , Aviano Cancer Center, Italy
  • Vita Dolzan , Pharmacogenetics Laboratory, Institute of Biochemistry, Faculty of Medicine, University of Ljubljana, Slovenia
  • Polat Dursun , Baskent University, Turkey
  • Piotr Dziegiel, Department of Histology and Embryology, Medical University of Wroclaw, Poland, Poland
  • Elisabeth Ersvaer, Department of Biomedical Laboratory Sciences and Chemical Engineering, Faculty of Engineering and Business Administration, Bergen University College, Bergen, Norway, Norway
  • Patrizia Ferroni , Department of Human Sciences and Quality of Life Promotion, San Raffaele Roma Open University, Italy
  • Shahinaz Gadalla, National Cancer Institute, USA
  • Maria Gazouli , University of Athens, Greece
  • Giuseppe Gorini, ISPO Cancer Research & Prevention Institute, Italy
  • Valeria Hirschler , University of Buenos Aires , Argentina
  • Karen Hirschman, University of Pennsylvania, USA
  • Cheryl L. Holt , University of Maryland, USA
  • Li Jiao, Baylor College of Medicine, USA
  • Ivor J. Katz, University of New South Wales, Australia
  • Jatinder Kaur, All India Institute of Medical Sciences, India
  • Srinivas Kondalsamy-Chennakesavan, The University of Queensland, Australia
  • Hasan Korkaya, University of Michigan, USA
  • Albert S Mellick, University of New South Wales, Australia
  • Harsh Mohan, Government Medical College, India
  • Daniel Neureiter , Salzburger Landeskliniken Universitätsklinikum, Austria
  • Khoa Nguyen , Stanford University, USA
  • Toshio Ohtsubo, Kyushu University, Japan
  • Nallasivam Palanisamy , University of Michigan, USA
  • Olga Pechanova , Institute of Normal and Pathological Physiology, Centre of Experimental Medicine, Slovak Academy of Sciences, Sienkiewiczova 1, 813 71 Bratislava, Slovakia
  • Sreekumar Pillai, Eli Lilly and company, USA
  • Srinivas R. Puli, University of Illinois, USA
  • Jayadev Raju, Health Canada, Canada
  • Kosagi S. Jagannatha Rao, Institute for Scientific Research and Technology Services, Panama
  • Mary Rhee , Emory University, USA
  • Tadeusz Robak , Medical University of Lodz, Poland
  • Mario Roselli, Department of Systems Medicine, Medical Oncology, University of Rome "Tor Vergata", Italy
  • Jochen G. Schneider , Universite' du Luxembourg, Germany
  • Fabrizio Stracci, Università degli Studi di Perugia, Italy
  • Feng Ru Tang , National University of Singapore, Singapore
  • Funda Tascioglu, Eskisehir Osmangazi Universitesi, Turkey
  • Peter Teismann, University of Aberdeen, United Kingdom
  • Jose Tellez-Zenteno, University of Saskatchewan, Canada
  • Gabriel J. Tobón , Fundación Valle del Lili, Colombia
  • Silverio Tomao, Università di Roma, Italy
  • Jaydutt V. Vadgama, Charles Drew University of Medicine and Science, USA
  • Martin C. S. Wong, The Chinese University of Hong Kong, Hong Kong
  • Adnan Yilmaz , Sureyyapasa Chest Diseases and Chest Surgery Training and Research Hospital, Turkey
  • Wan-Hee Yoo, Chonbuk National University, Republic of Korea
  • Katarzyna Zorena , Medical University of Gdansk, Poland
    International Journal of Chronic Diseases
     Journal metrics
    Acceptance rate20%
    Submission to final decision72 days
    Acceptance to publication41 days
    CiteScore-
    Impact Factor-
     Submit

    We are committed to sharing findings related to COVID-19 as quickly as possible. We will be providing unlimited waivers of publication charges for accepted research articles as well as case reports and case series related to COVID-19. Review articles are excluded from this waiver policy. Sign up here as a reviewer to help fast-track new submissions.